Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 21, 2018
MellingMedical was recently awarded a Federal Supply Schedule 65IB Drugs, Pharmaceuticals and Hematology Related Products.
read more
Wednesday, March 21, 2018
Enigma Biomedical Group announced execution of a Memorandum of Understanding to license Yale’s Synaptic Density Imaging biomarker technology platform
read more
Wednesday, March 21, 2018
Rho announced Lysa Triantafillou and Matt Healy have joined as director of quality assurance and vice president, clinical operations, respectively, at its headquarters in Chapel Hill, North Carolina
read more
Noramco and AFC announced a strategic partnership to produce certain US DEA controlled substances for use in the treatment of addiction, abuse prevention, cannabinoids for clinical indications, and ADHD.
read more
Grand River Aseptic Manufacturing (GRAM), a parenteral contract manufacturing organization, has signed purchase agreements to acquire land in Grand Rapids, Michigan.
read more
Recipharm has announced that its 2017 International Environmental Award will be presented to Karen Kidd, Professor in Biology, and Geography & Earth Sciences.
read more
AMPAC Fine Chemicals announced Lee Gauthier has joined AFC's executive team as Vice President of Operations responsible for manufacturing across all AFC's sites.
read more
Global pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce a laboratory expansion at its site in Tredegar, Wales, UK.
read more
Five Prime Therapeutics announced UCB has elected to exclusively license an undisclosed drug target for inflammatory diseases. Five Prime identified the target using its discovery platform.
read more
Hovione reported recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey, with the aim to increase capacity in existing technologies
read more
LabCorp announced its Covance Drug Development business has formed a global immunology and immunotoxicology unit dedicated to the specific needs of biologic drug development.
read more
BiondVax developer of the Universal Flu Vaccine candidate M-001, announced the signing of a MSA with a CRO to conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001.
read more
Ardena has acquired ChemConnection, a contract manufacturer of novel APIs and nanomedicines.
read more
Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm.
read more
Wednesday, March 14, 2018
Recipharm announces its new blow-fill-seal machinery is now operational following an investment last year at its facility in Kaysersberg, France.
read more